Elevance Health (MEX:ELV) Cyclically Adjusted Revenue per Share: MXN11,741.26 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ELV Elevance Health Inc MEX:ELV
80 GF Score
Price MXN6,449.00
GF Value MXN8,489.26
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Elevance Health Cyclically Adjusted Revenue per Share?

Elevance Health MEX:ELV 80 Cyclically Adjusted Revenue per Share is MXN11,741.26 as of Jun. 2026. GuruFocus rates MEX:ELV with a GF Score™ of 80/100 and a GF Value™ of MXN8,489.26 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Elevance Health's adjusted revenue per share for the three months ended in Jun. 2026 was MXN4,041.858. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN11,741.26 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Elevance Health's average Cyclically Adjusted Revenue Growth Rate was 11.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Elevance Health was 16.00% per year. The lowest was 11.80% per year. And the median was 13.20% per year.

As of today (2026-07-18), Elevance Health's current stock price is MXN6449.00. Elevance Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN11,741.26. Elevance Health's Cyclically Adjusted PS Ratio of today is 0.55.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Elevance Health was 1.29. The lowest was 0.46. And the median was 0.97.


Elevance Health  (MEX:ELV) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Elevance Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6449.00/11741.26
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Elevance Health was 1.29. The lowest was 0.46. And the median was 0.97.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Elevance Health Cyclically Adjusted Revenue per Share Related Terms


Elevance Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Elevance Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health Cyclically Adjusted Revenue per Share Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,720.94 8,723.90 9,002.24 11,721.57 10,707.12

Elevance Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,279.75 11,501.27 10,707.12 11,525.97 11,741.26

MEX:ELV vs CI, HUM, CVS: Cyclically Adjusted Revenue per Share Comparison

For the Healthcare Plans subindustry, Elevance Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevance Health Cyclically Adjusted PS Ratio vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Elevance Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Elevance Health's Cyclically Adjusted PS Ratio falls into.


MEX:ELV
80GF Score
Elevance Health Inc MEX:ELV
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Elevance Health's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4041.858/333.9520*333.9520
=4,041.858

Current CPI (Jun. 2026) = 333.9520.

Elevance Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1,543.659 241.428 2,135.245
201612 1,666.118 241.432 2,304.597
201703 1,568.566 243.801 2,148.579
201706 1,495.689 244.955 2,039.102
201709 1,524.296 246.819 2,062.409
201712 1,693.702 246.524 2,294.361
201803 1,558.003 249.554 2,084.912
201806 1,704.492 251.989 2,258.902
201809 1,638.696 252.439 2,167.834
201812 2,002.307 251.233 2,661.571
201903 1,824.137 254.202 2,396.418
201906 1,874.229 256.143 2,443.567
201909 2,025.377 256.759 2,634.294
201912 2,004.250 256.974 2,604.634
202003 2,708.866 258.115 3,504.760
202006 2,644.771 257.797 3,426.054
202009 2,707.755 260.280 3,474.182
202012 2,519.073 260.474 3,229.687
202103 2,667.130 264.877 3,362.668
202106 2,723.678 271.696 3,347.777
202109 2,994.195 274.310 3,645.209
202112 3,055.467 278.802 3,659.871
202203 3,103.558 287.504 3,604.956
202206 3,193.092 296.311 3,598.717
202209 3,316.982 296.808 3,732.085
202212 3,226.091 296.797 3,629.954
202303 3,171.257 301.836 3,508.686
202306 3,148.479 305.109 3,446.116
202309 3,155.951 307.789 3,424.216
202312 3,072.584 306.746 3,345.098
202403 3,017.159 312.332 3,226.010
202406 3,425.875 314.175 3,641.530
202409 3,813.465 315.301 4,039.043
202412 4,106.260 315.605 4,344.968
202503 4,402.385 319.799 4,597.217
202506 4,150.763 322.561 4,297.344
202509 4,158.483 324.800 4,275.658
202512 4,042.101 324.054 4,165.564
202603 4,105.712 330.213 4,152.201
202606 4,041.858 333.952 4,041.858

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN11,741.26 mean?
Elevance Health (MEX:ELV) has a Cyclically Adjusted Revenue per Share of MXN11,741.26 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Elevance Health and its competitors.
Is Elevance Health's Cyclically Adjusted Revenue per Share too high?
Elevance Health's current Cyclically Adjusted Revenue per Share is MXN11,741.26. Overall, Elevance Health has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Cyclically Adjusted Revenue per Share compare to CI and HUM?
Elevance Health's Cyclically Adjusted Revenue per Share of MXN11,741.26 can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Plans company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Plans industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Elevance Health and its competitors. Elevance Health's current Cyclically Adjusted Revenue per Share is MXN11,741.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN8,489.26, compared to a current price of MXN6,449.00 — trading 24% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN11,741.26. Elevance Health's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current Cyclically Adjusted Revenue per Share is MXN11,741.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (MEX:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of MXN6,449.00 is trading 24% below its estimated GF Value™ of MXN8,489.26. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for MEX:ELV:

  • Cyclically Adjusted Revenue per Share: MXN11,741.26
  • GF Value™: MXN8,489.26 vs. price of MXN6,449.00 (24% below fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
80GF Score

Get the complete analysis for MEX:ELV

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN6,449.00
Price
MXN8,489.26
GF Value